Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Pulmonary Hypertension

  Free Subscription


Articles published in Am J Respir Crit Care Med

Retrieve available abstracts of 205 articles:
HTML format



Single Articles


    September 2021
  1. ZHENG Z, Chen R, Zhang N, Zhuang C, et al
    Pulmonary Hypertension: A Predictor of Lung Cancer Prognosis?
    Am J Respir Crit Care Med. 2021 Sep 2. doi: 10.1164/rccm.202105-1256.
    PubMed    


  2. EUL B, Cekay M, Pullamsetti SS, Tello K, et al
    Reply to: Pulmonary Hypertension: A Predictor of Lung Cancer Prognosis?
    Am J Respir Crit Care Med. 2021 Sep 2. doi: 10.1164/rccm.202106-1411.
    PubMed    


    July 2021
  3. ZHANG Y, Michelakis ED
    A Phase-2 NIH-sponsored Randomized Clinical Trial of Rituximab in Scleroderma-associated Pulmonary Arterial Hypertension Did Not Reach Significance for Its Endpoints: End of Story? Not So Fast!
    Am J Respir Crit Care Med. 2021;204:123-125.
    PubMed    


    June 2021
  4. MARON BA, Abman SH, Elliott CG, Frantz RP, et al
    Pulmonary Arterial Hypertension: Diagnosis, Treatment, and Novel Advances.
    Am J Respir Crit Care Med. 2021;203:1472-1487.
    PubMed     Abstract available


  5. YUAN P, Wu WH, Gong SG, Jiang R, et al
    Impact of circGSAP in Peripheral Blood Mononuclear Cells on Idiopathic Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2021;203:1579-1583.
    PubMed    


  6. YAMASAKI Y, Kamitani T, Abe K, Hosokawa K, et al
    Diagnosis of Pulmonary Hypertension Using Dynamic Chest Radiography.
    Am J Respir Crit Care Med. 2021 Jun 8. doi: 10.1164/rccm.202102-0387.
    PubMed    


    April 2021
  7. HONG J, Arneson D, Umar S, Ruffenach G, et al
    Single-Cell Study of Two Rat Models of Pulmonary Arterial Hypertension Reveals Connections to Human Pathobiology and Drug Repositioning.
    Am J Respir Crit Care Med. 2021;203:1006-1022.
    PubMed     Abstract available


  8. MORELL E, Gaies M, Fineman JR, Charpie J, et al
    Mortality from Pulmonary Hypertension in the Pediatric Cardiac Intensive Care Unit.
    Am J Respir Crit Care Med. 2021 Apr 2. doi: 10.1164/rccm.202011-4183.
    PubMed     Abstract available


    March 2021
  9. FORBES LM, Gu S, Badesch DB
    Surrogate Markers for Pulmonary Hypertension May Inform Prognosis in Lung Cancer.
    Am J Respir Crit Care Med. 2021 Mar 31. doi: 10.1164/rccm.202103-0740.
    PubMed    


  10. WANG J, Yang K, Yuan JX
    NEDD9, a Hypoxia-upregulated Mediator for Pathogenic Platelet-endothelial Cell Interaction in Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2021 Mar 26. doi: 10.1164/rccm.202101-0007.
    PubMed    


  11. SOCKRIDER M, Roessel L, Fagan KA, Gillespie M, et al
    Diagnosis and Treatment of Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2021;203:P14-P15.
    PubMed    


  12. VIELE K, Girard TD
    Risk, Results, and Costs: Optimizing Clinical Trial Efficiency through Prognostic Enrichment.
    Am J Respir Crit Care Med. 2021;203:671-672.
    PubMed    


  13. HUMBERT M, Lau EMT
    Risk Stratification in Pulmonary Arterial Hypertension: Do Not Forget the Patient Perspective.
    Am J Respir Crit Care Med. 2021;203:675-677.
    PubMed    


  14. SCOTT JV, Garnett CE, Kanwar MK, Stockbridge NL, et al
    Enrichment Benefits of Risk Algorithms for Pulmonary Arterial Hypertension Clinical Trials.
    Am J Respir Crit Care Med. 2021;203:726-736.
    PubMed     Abstract available


  15. SOCKRIDER M
    What Is Pulmonary Hypertension?
    Am J Respir Crit Care Med. 2021;203:P12-P13.
    PubMed    


  16. AGARWAL S, de Jesus Perez VA
    In Defense of the Nucleus: NUDT1 and Oxidative DNA Damage in Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2021;203:541-542.
    PubMed    


  17. VITRY G, Paulin R, Grobs Y, Lampron MC, et al
    Oxidized DNA Precursors Cleanup by NUDT1 Contributes to Vascular Remodeling in Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2021;203:614-627.
    PubMed     Abstract available


    February 2021
  18. BONNET S, Gomez D
    RNA Methylation: A New Regulator of Vascular Remodeling in Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2021 Feb 26. doi: 10.1164/rccm.202011-4185.
    PubMed    


  19. BADAGLIACCA R, D'Alto M, Ghio S, Vizza CD, et al
    Reply to Weatherald et al.: Pulmonary Vascular Resistance in Pulmonary Arterial Hypertension: La Piece de Resistance?
    Am J Respir Crit Care Med. 2021;203:525-526.
    PubMed    


  20. WEATHERALD J, Boucly A, Savale L, Jais X, et al
    Pulmonary Vascular Resistance in Pulmonary Arterial Hypertension: La Piece de Resistance?
    Am J Respir Crit Care Med. 2021;203:524-525.
    PubMed    


  21. SCHOENBERG NC, Farber HW
    When "AMBITION" Isn't Good Enough: Risk Status and Dual Oral Therapy in Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2021;203:410-411.
    PubMed    


  22. KHURAL JS, Houston BA, Leary PJ, Mathai SC, et al
    Right Atrial Pacing to Improve Acute Hemodynamics in Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2021;203:508-511.
    PubMed    


  23. BADAGLIACCA R, D'Alto M, Ghio S, Argiento P, et al
    Risk Reduction and Hemodynamics with Initial Combination Therapy in Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2021;203:484-492.
    PubMed     Abstract available


  24. KARNES JH, Schwantes-An TH, Kittles R, Desai AA, et al
    Reply to Non and Chang: Challenging the Role of Genetic Ancestry in Explaining Racial/Ethnic Health Disparities.
    Am J Respir Crit Care Med. 2021;203:398-399.
    PubMed    


  25. NON AL, Chang SY
    Challenging the Role of Genetic Ancestry in Explaining Racial/Ethnic Health Disparities.
    Am J Respir Crit Care Med. 2021;203:397-398.
    PubMed    


  26. HIRAIDE T, Teratani T, Uemura S, Yoshimatsu Y, et al
    Pulmonary Arterial Hypertension Caused by AhR Signal Activation Protecting against Colitis.
    Am J Respir Crit Care Med. 2021;203:385-388.
    PubMed    


    January 2021
  27. HU L, Wang J, Huang H, Yu Y, et al
    YTHDF1 Regulates Pulmonary Hypertension Through Translational Control of MAGED1.
    Am J Respir Crit Care Med. 2021 Jan 19. doi: 10.1164/rccm.202009-3419.
    PubMed     Abstract available


  28. RODRIGUEZ-LOPEZ J, Wright CD, Stone JR, Farber H, et al
    When Imaging in Chronic Thromboembolic Pulmonary Hypertension Is Not Enough.
    Am J Respir Crit Care Med. 2021;203:e3-e4.
    PubMed    


  29. SYNN AJ, Li W, San Jose Estepar R, Washko GR, et al
    Pulmonary Vascular Pruning on Computed Tomography and Risk of Death in the Framingham Heart Study.
    Am J Respir Crit Care Med. 2021;203:251-254.
    PubMed    


  30. EUL B, Cekay M, Pullamsetti SS, Tello K, et al
    Non-invasive Surrogate Markers of PH are Associated with Poor Survival in Lung Cancer Patients.
    Am J Respir Crit Care Med. 2021 Jan 7. doi: 10.1164/rccm.202005-2023.
    PubMed    


    December 2020
  31. HUANG SK
    Knocking Out Smoking and Pulmonary Hypertension with a K().
    Am J Respir Crit Care Med. 2020 Dec 23. doi: 10.1164/rccm.202011-4121.
    PubMed    


  32. ALDRED MA
    PHorecasting Heritable Pulmonary Arterial Hypertension: Are We Nearly There Yet?
    Am J Respir Crit Care Med. 2020;202:1500-1502.
    PubMed    


  33. AMIN EK, Austin ED, Parker C, Colglazier E, et al
    Novel Documentation of Onset and Rapid Advancement of Pulmonary Arterial Hypertension without Symptoms in BMPR2 Mutation Carriers: Cautionary Tales?
    Am J Respir Crit Care Med. 2020;202:1587-1589.
    PubMed    


    November 2020
  34. MIN J, Badesch D, Chakinala M, Elwing J, et al
    Prediction of Health-Related Quality of Life and Hospitalization in Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association Registry (PHAR).
    Am J Respir Crit Care Med. 2020 Nov 19. doi: 10.1164/rccm.202010-3967.
    PubMed    


  35. CHELLADURAI P, Savai R, Pullamsetti SS
    Zooming into Cellular and Molecular Heterogeneity of Pulmonary Hypertension: What More Single-cell Omics Can Offer.
    Am J Respir Crit Care Med. 2020 Nov 10. doi: 10.1164/rccm.202010-3889.
    PubMed    


  36. MISNER K, Kass DJ
    A Plot TWIST in Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2020;202:1214-1216.
    PubMed    


    October 2020
  37. THENAPPAN T, Weir EK
    Pulmonary Arterial Hypertension and Sex in the Right Ventricle: It Is an Interesting Picture!
    Am J Respir Crit Care Med. 2020;202:928-929.
    PubMed    


  38. TELLO K, Richter MJ, Yogeswaran A, Ghofrani HA, et al
    Sex Differences in Right Ventricular-Pulmonary Arterial Coupling in Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2020;202:1042-1046.
    PubMed    


    September 2020
  39. L'HEUREUX M, Swiatek K, Guthrie R, Brath L, et al
    Pulmonary Hypertension: Advances in Risk Assessment and Emerging Procedures.
    Am J Respir Crit Care Med. 2020;202:745-747.
    PubMed    


    August 2020
  40. MARON BA
    Clarifying the Pulmonary Arterial Hypertension Molecular Landscape Using Functional Genetics.
    Am J Respir Crit Care Med. 2020;202:488-490.
    PubMed    


  41. RHODES CJ, Otero-Nunez P, Wharton J, Swietlik EM, et al
    Whole-Blood RNA Profiles Associated with Pulmonary Arterial Hypertension and Clinical Outcome.
    Am J Respir Crit Care Med. 2020;202:586-594.
    PubMed     Abstract available


    July 2020
  42. HAFEEZ N, Chan SY
    A New "TYK" Tok Era for the Study of Long Non-Coding RNAs in Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2020 Jul 29. doi: 10.1164/rccm.202007-2632.
    PubMed    


  43. FAN Y, Gu X, Zhang J, Sinn K, et al
    TWIST1 Drives Smooth Muscle Cell Proliferation in Pulmonary Hypertension via Loss of GATA-6 and BMPR2.
    Am J Respir Crit Care Med. 2020 Jul 21. doi: 10.1164/rccm.201909-1884.
    PubMed     Abstract available


  44. RUOPP NF, Farber HW
    The Elephant Man Meets Pulmonary Hypertension: A Cautionary Tale.
    Am J Respir Crit Care Med. 2020 Jul 15. doi: 10.1164/rccm.202006-2142.
    PubMed    


  45. BOTROS L, Szulcek R, Jansen SMA, Kurakula K, et al
    The Effects of Mercaptopurine on Pulmonary Vascular Resistance and BMPR2 Expression in Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2020;202:296-299.
    PubMed    


  46. ZEHENDNER CM, Valasarajan C, Werner A, Boeckel JN, et al
    Long Noncoding RNA TYKRIL Plays a Role in Pulmonary Hypertension via the p53-Mediated Regulation of PDGFRbeta.
    Am J Respir Crit Care Med. 2020 Jul 7. doi: 10.1164/rccm.201910-2041.
    PubMed     Abstract available


  47. GONCHAROVA EA, Chan SY, Ventetuolo CE, Weissmann N, et al
    Update in Pulmonary Vascular Diseases and Right Ventricular Dysfunction 2019.
    Am J Respir Crit Care Med. 2020;202:22-28.
    PubMed    


    June 2020
  48. ROCHON ER, Krowka MJ, Bartolome S, Heresi GA, et al
    BMP9/10 in Pulmonary Vascular Complications of Liver Disease.
    Am J Respir Crit Care Med. 2020;201:1575-1578.
    PubMed    


  49. AUSTIN ED, Hamid R
    Deconstructing the Melting Pot in Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2020;201:1329-1331.
    PubMed    


  50. KARNES JH, Wiener HW, Schwantes-An TH, Natarajan B, et al
    Genetic Admixture and Survival in Diverse Populations with Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2020;201:1407-1415.
    PubMed     Abstract available


    May 2020
  51. JUTANT EM, Jais X, Girerd B, Savale L, et al
    Phenotype and Outcomes of Pulmonary Hypertension Associated with Neurofibromatosis Type 1.
    Am J Respir Crit Care Med. 2020 May 21. doi: 10.1164/rccm.202001-0105.
    PubMed     Abstract available


  52. ALVAREZ RA, Berra L, Gladwin MT
    Home NO Therapy for COVID-19.
    Am J Respir Crit Care Med. 2020 May 21. doi: 10.1164/rccm.202005-1906.
    PubMed    


  53. MONTANI D, Jais X, Humbert M, Sitbon O, et al
    Pulmonary Hypertension Complicating Pulmonary Artery Involvement in Pseudoxanthoma Elasticum.
    Am J Respir Crit Care Med. 2020 May 15. doi: 10.1164/rccm.202002-0248.
    PubMed    


  54. GONCHAROVA EA, Simon MA, Yuan JX
    mTORC1 in Pulmonary Arterial Hypertension. At the Crossroads between Vasoconstriction and Vascular Remodeling?
    Am J Respir Crit Care Med. 2020;201:1177-1179.
    PubMed    


  55. HE Y, Zuo C, Jia D, Bai P, et al
    Loss of DP1 Aggravates Vascular Remodeling in Pulmonary Arterial Hypertension via mTORC1 Signaling.
    Am J Respir Crit Care Med. 2020;201:1263-1276.
    PubMed     Abstract available


  56. ZAMANIAN RT, Pollack CV Jr, Gentile MA, Rashid M, et al
    Outpatient Inhaled Nitric Oxide in a Patient with Vasoreactive IPAH and COVID-19 Infection.
    Am J Respir Crit Care Med. 2020 May 5. doi: 10.1164/rccm.202004-0937.
    PubMed    


  57. PLOSA EJ, Benjamin JT
    rhIGF-1 Therapy: A Silver Bullet for Bronchopulmonary Dysplasia Prevention?
    Am J Respir Crit Care Med. 2020;201:1032-1033.
    PubMed    


    April 2020
  58. CROUSER ED, Maier LA, Wilson KC, Bonham CA, et al
    Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline.
    Am J Respir Crit Care Med. 2020;201:e26-e51.
    PubMed     Abstract available


    March 2020
  59. HILL NS, Farber HW, Preston IR
    An Event-driven Trial for Oral Treprostinil. Progress but Not the Holy Grail.
    Am J Respir Crit Care Med. 2020;201:647-649.
    PubMed    


  60. WHITE RJ, Jerjes-Sanchez C, Bohns Meyer GM, Pulido T, et al
    Combination Therapy with Oral Treprostinil for Pulmonary Arterial Hypertension. A Double-Blind Placebo-controlled Clinical Trial.
    Am J Respir Crit Care Med. 2020;201:707-717.
    PubMed     Abstract available


  61. MULCHRONE A, Bellofiore A, Douwes JM, Duong N, et al
    Impaired Right Ventricular-Vascular Coupling in Young Adults Born Preterm.
    Am J Respir Crit Care Med. 2020;201:615-618.
    PubMed    


  62. MASA JF, Mokhlesi B, Benitez I, Mogollon MV, et al
    Echocardiographic Changes with Positive Airway Pressure Therapy in Obesity Hypoventilation Syndrome. Long-Term Pickwick Randomized Controlled Clinical Trial.
    Am J Respir Crit Care Med. 2020;201:586-597.
    PubMed     Abstract available


  63. HODGSON J, Swietlik EM, Salmon RM, Hadinnapola C, et al
    Characterization of GDF2 Mutations and Levels of BMP9 and BMP10 in Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2020;201:575-585.
    PubMed     Abstract available


    February 2020
  64. SEEDORF G, Kim C, Wallace B, Mandell EW, et al
    rhIGF-1/BP3 Preserves Lung Growth and Prevents Pulmonary Hypertension in Experimental BPD.
    Am J Respir Crit Care Med. 2020 Feb 26. doi: 10.1164/rccm.201910-1975.
    PubMed     Abstract available


  65. RICHTER MJ, Tello K
    Against the Odds: Risk Stratification with Cardiac Magnetic Resonance Imaging in Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2020;201:403-405.
    PubMed    


  66. LEWIS RA, Johns CS, Cogliano M, Capener D, et al
    Identification of Cardiac Magnetic Resonance Imaging Thresholds for Risk Stratification in Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2020;201:458-468.
    PubMed     Abstract available


  67. CHEN L, Liu C, Lu W, Wang T, et al
    BET Signaling, A Novel Therapeutic Target for Pulmonary Hypertension?
    Am J Respir Crit Care Med. 2020 Feb 7. doi: 10.1164/rccm.201912-2525.
    PubMed    


  68. PROVENCHER S, Boucherat O, Berger RMF, Goumans MJ, et al
    Reply to: BET Signaling, A Novel Therapeutic Target for Pulmonary Hypertension?
    Am J Respir Crit Care Med. 2020 Feb 7. doi: 10.1164/rccm.202001-0059.
    PubMed    


  69. NING D, Du J, Yang XQ, Wang DX, et al
    More Insights into the Association between RVX-208 and Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2020;201:388-389.
    PubMed    


  70. PROVENCHER S, Boucherat O, Berger RMF, Goumans MJ, et al
    Reply to Ning et al.: More Insights into the Association between RVX-208 and Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2020;201:389-391.
    PubMed    


    January 2020
  71. NICKEL NP, Yuan K, Dorfmuller P, Provencher S, et al
    Beyond the Lungs: Systemic Manifestations of Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2020;201:148-157.
    PubMed     Abstract available


  72. HON S, Channick RN, Farber HW
    Unilateral Chronic Thromboembolic Pulmonary Disease: A Mimic of Pulmonary Artery Agenesis.
    Am J Respir Crit Care Med. 2020 Jan 3. doi: 10.1164/rccm.201905-0997.
    PubMed    


  73. HASSOUN PM
    Early Detection of Pulmonary Vascular Dysfunction in Neonatal Bronchopulmonary Dysplasia.
    Am J Respir Crit Care Med. 2020;201:7-9.
    PubMed    


  74. PARK JB, Suh M, Park JY, Park JK, et al
    Assessment of Inflammation in Pulmonary Artery Hypertension by (68)Ga-Mannosylated Human Serum Albumin.
    Am J Respir Crit Care Med. 2020;201:95-106.
    PubMed     Abstract available


    November 2019
  75. BOGAARD HJ, Legchenko E, Ackermann M, Kuhnel MP, et al
    Reply to: Early Disruption of VEGF Receptor Signalling and the Risk for Adult Emphysema.
    Am J Respir Crit Care Med. 2019 Nov 26. doi: 10.1164/rccm.201910-1983.
    PubMed    


  76. LE CRAS TD, Abman SH
    Early Disruption of VEGF Receptor Signaling and the Risk for Adult Emphysema.
    Am J Respir Crit Care Med. 2019 Nov 26. doi: 10.1164/rccm.201909-1698.
    PubMed    


  77. HAARMAN MG, Douwes JM, Ploegstra MJ, Roofthooft MTR, et al
    The Clinical Value of Proposed Risk Stratification Tools in Pediatric Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2019;200:1312-1315.
    PubMed    


  78. AL-NAAMANI N, Ventetuolo CE
    Another Piece in the Estrogen Puzzle of Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2019 Nov 5. doi: 10.1164/rccm.201910-1982.
    PubMed    


  79. PIQUEREAU J, Perros F
    BET Bromodomain Inhibitors and Pulmonary Arterial Hypertension: Take Care of the Heart.
    Am J Respir Crit Care Med. 2019;200:1187-1188.
    PubMed    


  80. PULLAMSETTI SS, de Jesus Perez VA
    EpiHope for the Treatment of Pulmonary Arterial Hypertension: Selective versus Nonselective BET Inhibition.
    Am J Respir Crit Care Med. 2019;200:1188-1190.
    PubMed    


  81. KURAKULA K, Boucherat O, Van der Feen DE, Bogaard HJ, et al
    Reply to Piquereau and Perros and to Pullamsetti and de Jesus Perez.
    Am J Respir Crit Care Med. 2019;200:1190-1191.
    PubMed    


    October 2019
  82. PHILIP JL, Tabima DM, Wolf GD, Frump AL, et al
    Exogenous Estrogen Preserves Distal Pulmonary Arterial Mechanics and Prevents Pulmonary Hypertension in Rats.
    Am J Respir Crit Care Med. 2019 Oct 29. doi: 10.1164/rccm.201906-1217.
    PubMed    


  83. WAMBACH JA, Nogee LM
    A Step toward Treating a Lethal Neonatal Lung Disease. STAT3 and Alveolar Capillary Dysplasia.
    Am J Respir Crit Care Med. 2019;200:961-962.
    PubMed    


  84. PRADHAN A, Dunn A, Ustiyan V, Bolte C, et al
    The S52F FOXF1 Mutation Inhibits STAT3 Signaling and Causes Alveolar Capillary Dysplasia.
    Am J Respir Crit Care Med. 2019;200:1045-1056.
    PubMed     Abstract available


  85. GRUNIG G, Durmus N
    An Emotional Molecular Pathway in Pulmonary Hypertension - Alternative Complement System.
    Am J Respir Crit Care Med. 2019 Oct 10. doi: 10.1164/rccm.201909-1790.
    PubMed    


  86. DAI Z, Zhao YY
    BET in Pulmonary Arterial Hypertension: Exploration of BET Inhibitors to Reverse Vascular Remodeling.
    Am J Respir Crit Care Med. 2019;200:806-808.
    PubMed    


  87. VAN DER FEEN DE, Kurakula K, Tremblay E, Boucherat O, et al
    Multicenter Preclinical Validation of BET Inhibition for the Treatment of Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2019;200:910-920.
    PubMed     Abstract available


    September 2019
  88. FRID MG, McKeon BA, Thurman JM, Maron BA, et al
    Immunoglobulin-Driven Complement Activation Regulates Pro-Inflammatory Remodeling in Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2019 Sep 23. doi: 10.1164/rccm.201903-0591.
    PubMed     Abstract available


  89. RICHTER MJ, Peters D, Ghofrani HA, Naeije R, et al
    Evaluation and Prognostic Relevance of Right Ventricular-Arterial Coupling in Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2019 Sep 20. doi: 10.1164/rccm.201906-1195.
    PubMed    


  90. CRITSER PJ, Higano NS, Tkach JA, Olson ES, et al
    Cardiac MRI Evaluation of Neonatal Bronchopulmonary Dysplasia Associated Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2019 Sep 20. doi: 10.1164/rccm.201904-0826.
    PubMed     Abstract available


  91. BONNET S, Paulin R
    Involvement of PFKFB3 in Pulmonary Arterial Hypertension Pathogenesis. Is It All about Glycolysis?
    Am J Respir Crit Care Med. 2019;200:532-534.
    PubMed    


  92. KOVACS L, Cao Y, Han W, Meadows L, et al
    PFKFB3 in Smooth Muscle Promotes Vascular Remodeling in Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2019;200:617-627.
    PubMed     Abstract available


    August 2019
  93. BOGAARD HJ, Legchenko E, Chaudhary KR, Sun X, et al
    Emphysema is - at the most - only a Mild Phenotype in the Sugen-Hypoxia Rat Model of Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2019 Aug 22. doi: 10.1164/rccm.201906-1200.
    PubMed    


  94. KOJONAZAROV B, Hadzic S, Ghofrani HA, Grimminger F, et al
    Reply to: Emphysema is - at the most - only a Mild Phenotype in the Sugen-Hypoxia Rat Model of Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2019 Aug 22. doi: 10.1164/rccm.201907-1367.
    PubMed    


  95. WEATHERALD J, Montani D, Humbert M
    Seeing the Forest for the (Arterial) Tree: Vascular Pruning and the Chronic Obstructive Pulmonary Disease Pulmonary Vascular Phenotype.
    Am J Respir Crit Care Med. 2019;200:406-408.
    PubMed    


    June 2019
  96. SIMPSON CE, Hassoun PM
    Myocardial Fibrosis as a Potential Maladaptive Feature of RV Remodeling in Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2019 Jun 19. doi: 10.1164/rccm.201906-1154.
    PubMed    


  97. GRINNAN D, Farkas L
    A Novel Peptide for Immunomodulation in Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2019;199:1460-1461.
    PubMed    


  98. GOLDENBERG NM, Hu Y, Hu X, Volchuk A, et al
    Therapeutic Targeting of High-Mobility Group Box-1 in Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2019;199:1566-1569.
    PubMed    


  99. BERGER RMF, Beghetti M
    Early Diagnosis in Pulmonary Arterial Hypertension: The Search for the Holy Grail.
    Am J Respir Crit Care Med. 2019;199:1306-1307.
    PubMed    


  100. KOHLI P, Kelly VJ, Kehl EG, Rodriguez-Lopez J, et al
    Perfusion Imaging Distinguishes Exercise Pulmonary Arterial Hypertension at Rest.
    Am J Respir Crit Care Med. 2019;199:1438-1441.
    PubMed    


  101. TELLO K, Dalmer A, Husain-Syed F, Seeger W, et al
    Multibeat Right Ventricular-Arterial Coupling during a Positive Acute Vasoreactivity Test.
    Am J Respir Crit Care Med. 2019;199:e41-e42.
    PubMed    


  102. SAWADA H, Mitani Y, Nakayama T, Fukushima H, et al
    Detection of Pediatric Pulmonary Arterial Hypertension by School Electrocardiography Mass Screening.
    Am J Respir Crit Care Med. 2019;199:1397-1406.
    PubMed     Abstract available


    May 2019
  103. JANKOWICH M, Abbasi SA, Vang A, Choudhary G, et al
    Right Ventricular Fibrosis is Related to Pulmonary Artery Stiffness in Pulmonary Hypertension: A Cardiac Magnetic Resonance Imaging Study.
    Am J Respir Crit Care Med. 2019 May 30. doi: 10.1164/rccm.201903-0580.
    PubMed    


  104. RUIGROK D, Meijboom LJ, Westerhof BE, In 't Veld AH, et al
    Right Ventricular Load and Function in Chronic Thromboembolic Pulmonary Hypertension: Differences between Proximal and Distal Chronic Thromboembolic Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2019;199:1163-1166.
    PubMed    


    April 2019
  105. SIMON MA, Maron BA
    Pulmonary Hypertension in Heart Failure with Preserved Ejection Fraction Patients: Where to Draw the Line.
    Am J Respir Crit Care Med. 2019 Apr 30. doi: 10.1164/rccm.201903-0689.
    PubMed    


  106. KOJONAZAROV B, Hadzic S, Ghofrani HA, Grimminger F, et al
    Severe Emphysema in the SU5416/Hypoxia Rat Model of Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2019 Apr 29. doi: 10.1164/rccm.201902-0390.
    PubMed    


  107. TOSHNER M
    BMP9 Morphs into a Potential Player in Portopulmonary Hypertension.
    Am J Respir Crit Care Med. 2019;199:819-821.
    PubMed    


  108. NIKOLIC I, Yung LM, Yang P, Malhotra R, et al
    Bone Morphogenetic Protein 9 Is a Mechanistic Biomarker of Portopulmonary Hypertension.
    Am J Respir Crit Care Med. 2019;199:891-902.
    PubMed     Abstract available


    March 2019
  109. NISHIHARA T, Yamamoto E, Tokitsu T, Sueta D, et al
    New Definition of Pulmonary Hypertension in Heart Failure with Preserved Ejection Fraction Patients.
    Am J Respir Crit Care Med. 2019 Mar 27. doi: 10.1164/rccm.201901-0148.
    PubMed    


  110. TANGUAY VF, Babin C, Giardetti G, Sohier-Poirier C, et al
    Enhanced Pulmonary Artery Radiodensity in Pulmonary Arterial Hypertension: A Sign of Early Calcification?
    Am J Respir Crit Care Med. 2019;199:799-802.
    PubMed    


    February 2019
  111. TRANKLE CR, Canada JM, Kadariya D, Markley R, et al
    IL-1 Blockade Reduces Inflammation in Pulmonary Arterial Hypertension and Right Ventricular Failure: A Single-Arm, Open-Label, Phase IB/II Pilot Study.
    Am J Respir Crit Care Med. 2019;199:381-384.
    PubMed    


    January 2019
  112. GRAHAM BB, Yu PB
    Finding the Target: In Silico and Genetic Screening for Mechanistically Novel Drugs in Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2019;199:9-11.
    PubMed    


  113. DANNEWITZ PROSSEDA S, Tian X, Kuramoto K, Boehm M, et al
    FHIT, a Novel Modifier Gene in Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2019;199:83-98.
    PubMed     Abstract available


    December 2018
  114. SUNDD P, Kuebler WM
    Smooth Muscle Cells: A Novel Site of P-selectin Expression with Pathophysiological and Therapeutic Relevance in Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2018 Dec 28. doi: 10.1164/rccm.201812-2242.
    PubMed    


  115. NOVOYATLEVA T, Kojonazarov B, Owczarek A, Veeroju S, et al
    Evidence for Fucoidan-P-selectin Axis as a Therapeutic Target on Hypoxia-induced Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2018 Dec 17. doi: 10.1164/rccm.201806-1170.
    PubMed     Abstract available


  116. MULLIN CJ, Kato GJ, Ventetuolo CE
    Anakinra, What is Thy Bidding in Pulmonary Hypertension?
    Am J Respir Crit Care Med. 2018 Dec 12. doi: 10.1164/rccm.201811-2192.
    PubMed    


    September 2018
  117. GRUNIG G, Durmus N
    An RNA Sensor Protects from Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2018 Sep 25. doi: 10.1164/rccm.201807-1363.
    PubMed    



  118. Erratum: Galectin-3 Promotes Vascular Remodeling and Contributes to Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2018;198:824.
    PubMed    


  119. FARKAS D, Thompson AAR, Bhagwani AR, Hultman S, et al
    Toll-like Receptor 3 is a Therapeutic Target for Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2018 Sep 13. doi: 10.1164/rccm.201707-1370.
    PubMed     Abstract available


    August 2018
  120. SOFER A, Lee S, Papangeli I, Adachi T, et al
    Therapeutic Engagement of the HDAC IIA-MEF2 Axis Improves Experimental Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2018 Aug 14. doi: 10.1164/rccm.201805-0817.
    PubMed    


    July 2018
  121. SHIMODA LA
    What's HIF Got to Do with It? HIF-2 Inhibition and Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2018 Jul 12. doi: 10.1164/rccm.201806-1130.
    PubMed    


    June 2018
  122. ELINOFF JM, Humbert M, Solomon MA
    Reply to: The Light at the End of the Long Pulmonary Hypertension Tunnel Brightens.
    Am J Respir Crit Care Med. 2018 Jun 26. doi: 10.1164/rccm.201804-0792.
    PubMed    


  123. VOELKEL NF, Newman JH
    The Light at the End of the Long Pulmonary Hypertension Tunnel Brightens.
    Am J Respir Crit Care Med. 2018 Jun 26. doi: 10.1164/rccm.201802-0325.
    PubMed    


    May 2018
  124. GONCHAROV DA, Goncharova EA, Tofovic SP, Hu J, et al
    Metformin Therapy for Pulmonary Hypertension Associated with HFpEF versus PAH.
    Am J Respir Crit Care Med. 2018 May 4. doi: 10.1164/rccm.201801-0022.
    PubMed    


    April 2018
  125. STENMARK KR, Hu CJ, Pullamsetti SS
    How Many Foxs Are There on the Road to Pulmonary Hypertension?
    Am J Respir Crit Care Med. 2018 Apr 25. doi: 10.1164/rccm.201804-0702.
    PubMed    


  126. DAI Z, Zhu MM, Peng Y, Jin H, et al
    Endothelial and Smooth Muscle Cell Interaction via FoxM1 Signaling Mediates Vascular Remodeling and Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2018 Apr 17. doi: 10.1164/rccm.201709-1835.
    PubMed     Abstract available


  127. AGARWAL MA, Shah M, Patel B, Nolan VG, et al
    Association between Pulmonary Hypertension and Clinical Outcomes in Hospitalized Sickle Cell Disease Patients.
    Am J Respir Crit Care Med. 2018 Apr 12. doi: 10.1164/rccm.201802-0261.
    PubMed    


  128. HU Y, Zabini D, Gu W, Goldenberg NM, et al
    The Role of the Human Immune System in Chronic Hypoxic Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2018 Apr 9. doi: 10.1164/rccm.201711-2175.
    PubMed    


    March 2018
  129. WEST JD, Carrier EJ
    Precision Modeling of Pulmonary Hypertension Pathology with iPSC-derived Cells.
    Am J Respir Crit Care Med. 2018 Mar 29. doi: 10.1164/rccm.201803-0480.
    PubMed    


  130. BARNES JW, Patel RP
    Things We 'kNOw' and Don't 'kNOw' About Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2018 Mar 28. doi: 10.1164/rccm.201803-0424.
    PubMed    


  131. ZHANG J, Dong J, Martin M, He M, et al
    AMPK Phosphorylation of ACE2 in Endothelium Mitigates Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2018 Mar 23. doi: 10.1164/rccm.201712-2570.
    PubMed     Abstract available


    February 2018
  132. OGOSHI T, Tsutsui M, Kido T, Sakanashi M, et al
    Protective Role of Myelocytic Nitric Oxide Synthases Against Hypoxic Pulmonary Hypertension in Mice.
    Am J Respir Crit Care Med. 2018 Feb 26. doi: 10.1164/rccm.201709-1783.
    PubMed     Abstract available



  133. Chronic Thromboembolic Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2018;197:P5-P6.
    PubMed    


  134. LEARY PJ, Hess E, Baron AE, Branch KR, et al
    H2-receptor Antagonist Use and Mortality in Pulmonary Hypertension: Insight from the VA-CART Program.
    Am J Respir Crit Care Med. 2018 Feb 13. doi: 10.1164/rccm.201801-0048.
    PubMed    


  135. ELINOFF JM, Agarwal R, Barnett CF, Benza RL, et al
    Challenges in Pulmonary Hypertension: Controversies in Treating the Tip of the Iceberg.
    Am J Respir Crit Care Med. 2018 Feb 9. doi: 10.1164/rccm.201710-2093.
    PubMed     Abstract available


  136. BUDAS GR, Boehm M, Kojonazarov B, Viswanathan G, et al
    ASK1 Inhibition Halts Disease Progression in Preclinical Models of Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2018;197:373-385.
    PubMed     Abstract available


  137. MERCURIO V, Mukherjee M, Tedford RJ, Zamanian RT, et al
    Improvement in Right Ventricular Strain with Ambrisentan and Tadalafil Upfront Therapy in Scleroderma-associated Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2018;197:388-391.
    PubMed    


  138. WAGNER BD, Babinec AE, Carpenter C, Gonzalez S, et al
    Proteomic Profiles Associated with Early Echocardiogram Evidence of Pulmonary Vascular Disease in Preterm Infants.
    Am J Respir Crit Care Med. 2018;197:394-397.
    PubMed    


    January 2018
  139. BARMAN SA, Chen F, Li X, Haigh S, et al
    Galectin-3 Promotes Vascular Remodeling and Contributes to Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2018 Jan 24. doi: 10.1164/rccm.201711-2308.
    PubMed    


  140. PRINS KW, Rose L, Archer SL, Pritzker M, et al
    Disproportionate Right Ventricular Dysfunction and Poor Survival in Group 3 Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2018 Jan 23. doi: 10.1164/rccm.201712-2405.
    PubMed    


  141. ZABINI D, Granton E, Hu Y, Miranda MZ, et al
    Loss of SMAD3 Promotes Vascular Remodeling in Pulmonary Arterial Hypertension via MRTF Disinhibition.
    Am J Respir Crit Care Med. 2018;197:244-260.
    PubMed     Abstract available


    December 2017
  142. MARON BA, Wertheim BM, Gladwin MT
    Under Pressure to Clarify Pulmonary Hypertension Clinical Risk.
    Am J Respir Crit Care Med. 2017 Dec 7. doi: 10.1164/rccm.201711-2306.
    PubMed    


  143. ZHANG HD, Lv ZC, Wang LT, Rothman A, et al
    Prognostic Significance of Reduced Blood Pressure Response to Exercise in Pediatric Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2017;196:1478-1481.
    PubMed    


    November 2017
  144. ROMAN BL, Cuttica MJ
    Classifying Pulmonary Hypertension in Hereditary Hemorrhagic Telangiectasia. Hemodynamics Matter.
    Am J Respir Crit Care Med. 2017;196:1244-1246.
    PubMed    


  145. CHUN HJ, Bonnet S, Chan SY
    Reply: Transforming Growth Factor beta1- and Bone Morphogenetic Protein 2/PPARgamma-regulated MicroRNAs in Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2017;196:1228-1229.
    PubMed    


  146. CALVIER L, Chouvarine P, Legchenko E, Hansmann G, et al
    Transforming Growth Factor beta1- and Bone Morphogenetic Protein 2/PPARgamma-regulated MicroRNAs in Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2017;196:1227-1228.
    PubMed    


    October 2017

  147. Pulmonary Hypertension in Children.
    Am J Respir Crit Care Med. 2017;196:P15-P16.
    PubMed    


  148. TALWAR A, Garcia JGN, Tsai H, Moreno M, et al
    Health Disparities in Patients with Pulmonary Arterial Hypertension: A Blueprint for Action. An Official American Thoracic Society Statement.
    Am J Respir Crit Care Med. 2017;196:e32-e47.
    PubMed     Abstract available


  149. AUSTIN ED, Hamid R
    Y Not? Sex Chromosomes May Modify Sexual Dimorphism in Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2017 Oct 2. doi: 10.1164/rccm.201709-1865.
    PubMed    


  150. LIU D, Yan Y, Chen JW, Yuan P, et al
    Hypermethylation of BMPR2 Promoter Occurs in Patients with Heritable Pulmonary Arterial Hypertension and Inhibits BMPR2 Expression.
    Am J Respir Crit Care Med. 2017;196:925-928.
    PubMed    


    September 2017
  151. UMAR S, Cunningham CM, Itoh Y, Moazeni S, et al
    The Y Chromosome Plays a Protective Role in Experimental Hypoxic Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2017 Sep 21. doi: 10.1164/rccm.201707-1345.
    PubMed    


  152. WILKINS MR
    Apoptosis Signal-regulating Kinase 1 Inhibition in Pulmonary Hypertension: Too Much to ASK?
    Am J Respir Crit Care Med. 2017 Sep 20. doi: 10.1164/rccm.201709-1814.
    PubMed    


  153. ACKERMANN M, Gaumann A, Mentzer SJ, Hinrichs JB, et al
    Plexiform Vasculopathy in Chronic Thromboembolic Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2017 Sep 11. doi: 10.1164/rccm.201703-0591.
    PubMed    


    July 2017
  154. SWIFT AJ, Capener D, Johns C, Hamilton N, et al
    Magnetic Resonance Imaging in the Prognostic Evaluation of Patients with Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2017;196:228-239.
    PubMed     Abstract available


  155. ZIJLSTRA WMH, Ploegstra MJ, Vissia-Kazemier T, Roofthooft MTR, et al
    Physical Activity in Pediatric Pulmonary Arterial Hypertension Measured by Accelerometry. A Candidate Clinical Endpoint.
    Am J Respir Crit Care Med. 2017;196:220-227.
    PubMed     Abstract available


  156. MATHAI SC, Kawut SM
    Magnetic Resonance Imaging in Pulmonary Arterial Hypertension. Panacea or Pixelation?
    Am J Respir Crit Care Med. 2017;196:129-131.
    PubMed    


  157. AUSTIN ED, Feinstein JA
    Accelerometry: Improving Objective Assessments of Therapeutic Impact in Pediatric Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2017;196:127-129.
    PubMed    


    June 2017
  158. BARNES JW, Dweik RA
    Pulmonary Hypertension and Precision Medicine through the "Omics" Looking Glass.
    Am J Respir Crit Care Med. 2017;195:1558-1560.
    PubMed    


  159. NEWMAN JH, Rich S, Abman SH, Alexander JH, et al
    Enhancing Insights into Pulmonary Vascular Disease through a Precision Medicine Approach. A Joint NHLBI-Cardiovascular Medical Research and Education Fund Workshop Report.
    Am J Respir Crit Care Med. 2017;195:1661-1670.
    PubMed     Abstract available


    May 2017

  160. Chronic Thromboembolic Pulmonary Hypertension: Part 1.
    Am J Respir Crit Care Med. 2017;195:P19-P20.
    PubMed    


  161. NICOLLS MR, Voelkel NF
    The Roles of Immunity in the Prevention and Evolution of Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2017;195:1292-1299.
    PubMed    


    April 2017
  162. FERNANDES TM, Pretorius VG, Kim NH
    Caution Regarding Catheter-directed Thrombolysis: Chronic Thromboembolic Pulmonary Hypertension Mistaken for Acute Submassive Pulmonary Embolism.
    Am J Respir Crit Care Med. 2017;195:1066-1067.
    PubMed    


  163. CHIZINGA M, Rudkovskaia AA, Henderson K, Pollak J, et al
    Pulmonary Hypertension Prevalence and Prognosis in a Cohort of Patients with Hereditary Hemorrhagic Telangiectasia Undergoing Embolization of pAVMs.
    Am J Respir Crit Care Med. 2017 Apr 4. doi: 10.1164/rccm.201702-0267.
    PubMed    


  164. SA S, Gu M, Chappell J, Shao NY, et al
    Induced Pluripotent Stem Cell Model of Pulmonary Arterial Hypertension Reveals Novel Gene Expression and Patient Specificity.
    Am J Respir Crit Care Med. 2017;195:930-941.
    PubMed     Abstract available


  165. HAMID R, Yan L
    Induced Pluripotent Stem Cells in Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2017;195:852-853.
    PubMed    


    March 2017
  166. GRAHAM BB, Koyanagi D, Kandasamy B, Tuder RM, et al
    Right Ventricle Vasculature in Human Pulmonary Hypertension Assessed by Stereology.
    Am J Respir Crit Care Med. 2017 Mar 9. doi: 10.1164/rccm.201702-0425.
    PubMed    


  167. BONNET S, Provencher S, Guignabert C, Perros F, et al
    Translating Research into Improved Patient Care in Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2017;195:583-595.
    PubMed    


    February 2017
  168. HONG Z, Chen KH, DasGupta A, Potus F, et al
    MicroRNA-138 and MicroRNA-25 Down-regulate Mitochondrial Calcium Uniporter, Causing the Pulmonary Arterial Hypertension Cancer Phenotype.
    Am J Respir Crit Care Med. 2017;195:515-529.
    PubMed     Abstract available


  169. GUPTE SA, Wolin MS
    Mitochondrial Calcium Transport: A Potentially Prominent, Therapeutically Targetable Contributor to Pulmonary Arterial Hypertension Progression.
    Am J Respir Crit Care Med. 2017;195:420-421.
    PubMed    


  170. PULLAMSETTI SS, Savai R, Seeger W, Goncharova EA, et al
    Translational Advances in the Field of Pulmonary Hypertension. From Cancer Biology to New Pulmonary Arterial Hypertension Therapeutics. Targeting Cell Growth and Proliferation Signaling Hubs.
    Am J Respir Crit Care Med. 2017;195:425-437.
    PubMed    


  171. KAWUT SM, Archer-Chicko CL, DeMichele A, Fritz JS, et al
    Anastrozole in Pulmonary Arterial Hypertension. A Randomized, Double-Blind, Placebo-controlled Trial.
    Am J Respir Crit Care Med. 2017;195:360-368.
    PubMed     Abstract available


  172. BAILLIE TJ, Sidharta S, Steele PM, Worthley SG, et al
    Noninvasive Assessment of Cardiopulmonary Reserve: Toward Early Detection of Pulmonary Vascular Disease.
    Am J Respir Crit Care Med. 2017;195:398-401.
    PubMed    


  173. LEBERKUHNE LJ, Ploegstra MJ, Douwes JM, Bartelds B, et al
    Serially Measured Uric Acid Levels Predict Disease Severity and Outcome in Pediatric Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2017;195:401-404.
    PubMed    


  174. LAHM T, Frump AL
    Toward Harnessing Sex Steroid Signaling as a Therapeutic Target in Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2017;195:284-286.
    PubMed    


    January 2017
  175. BRUSSELLE G, Bracke K, De Pauw M
    Peripheral Artery Disease in Patients with Chronic Obstructive Pulmonary Disease.
    Am J Respir Crit Care Med. 2017;195:148-150.
    PubMed    


  176. GLADWIN MT
    Translational Advances in the Field of Pulmonary Hypertension Bench to Bedside: How Fundamental Discoveries in Science Are Advancing Our Understanding and Therapy of Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2017;195:1-3.
    PubMed    


  177. AUSTIN ED, West J, Loyd JE, Hemnes AR, et al
    Translational Advances in the Field of Pulmonary Hypertension Molecular Medicine of Pulmonary Arterial Hypertension. From Population Genetics to Precision Medicine and Gene Editing.
    Am J Respir Crit Care Med. 2017;195:23-31.
    PubMed    


    November 2016
  178. MARON BA, Abman SH
    Focusing on Developmental Origins and Disease Inception for the Prevention of Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2016.
    PubMed     Abstract available


  179. KAMENY RJ, Fineman JR
    The Prescient Prognosticator? Hepatoma-derived Growth Factor in Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2016;194:1186-1187.
    PubMed    


  180. KUEBLER WM
    Vascular Calcification in Pulmonary Hypertension. Another Brick in the Wall.
    Am J Respir Crit Care Med. 2016;194:1187-1189.
    PubMed    


  181. BERRA L, Rodriguez-Lopez J, Rezoagli E, Yu B, et al
    Electric Plasma-generated Nitric Oxide: Hemodynamic Effects in Patients with Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2016;194:1168-1170.
    PubMed    


    October 2016
  182. ABMAN SH, Ivy DD, Archer SL, Wilson K, et al
    Executive Summary of the American Heart Association and American Thoracic Society Joint Guidelines for Pediatric Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2016;194:898-906.
    PubMed     Abstract available


  183. BOUCHERAT O, Bonnet S, Paulin R
    The HIPPO-Thesis of Pulmonary HYPERtension.
    Am J Respir Crit Care Med. 2016;194:787-789.
    PubMed    


    September 2016
  184. CHUN HJ, Bonnet S, Chan SY
    Translating MicroRNA Biology in Pulmonary Hypertension: It Will Take More Than "miR" Words.
    Am J Respir Crit Care Med. 2016.
    PubMed     Abstract available


    May 2016
  185. TOFOVIC SP, Jackson EK
    Estrogens in Men: Another Layer of Complexity of Estradiol Metabolism in Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2016;193:1087-90.
    PubMed    


  186. WHITE RJ
    Estrogen: Friend or Foe in Pulmonary Hypertension?
    Am J Respir Crit Care Med. 2016;193:1084-6.
    PubMed    


    April 2016
  187. KUDRYASHOVA TV, Goncharov DA, Pena A, Kelly N, et al
    HIPPO-integrin Linked Kinase Crosstalk Controls Self-sustaining Proliferation and Survival in Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2016.
    PubMed     Abstract available


  188. YUNG LM, Nikolic I, Paskin-Flerlage SD, Pearsall RS, et al
    A Selective TGFbeta Ligand Trap Attenuates Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2016.
    PubMed     Abstract available


  189. NIKOLIC I, Yu PB
    The Role of Bone Marrow-derived Cells in Pulmonary Arterial Hypertension. What Lies Beneath?
    Am J Respir Crit Care Med. 2016;193:822-4.
    PubMed    


  190. YAN L, Chen X, Talati M, Nunley BW, et al
    Bone Marrow-derived Cells Contribute to the Pathogenesis of Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2016;193:898-909.
    PubMed     Abstract available


  191. LIPTZIN DR, Sturgill M, Kim J, Abman SH, et al
    An Unusual Etiology of Infantile Hemoptysis.
    Am J Respir Crit Care Med. 2016;193:e14-5.
    PubMed    


    March 2016
  192. GALAMBOS C, Sims-Lucas S, Abman SH, Cool CD, et al
    Intrapulmonary Bronchopulmonary Anastomoses and Plexiform Lesions in Idiopathic Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2016;193:574-6.
    PubMed    


  193. ST CROIX CM, Steinhorn RH
    New Thoughts about the Origin of Plexiform Lesions.
    Am J Respir Crit Care Med. 2016;193:484-5.
    PubMed    


    November 2015
  194. VANDERPOOL RR, Naeije R
    Progress in Pulmonary Hypertension with Left Heart Failure. Beyond New Definitions and Acronyms.
    Am J Respir Crit Care Med. 2015;192:1152-4.
    PubMed    


    October 2015
  195. ATAYA A, Barretto J, Wynne J, Faruqi I, et al
    Beyond the Blue: Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2015.
    PubMed    


  196. GRUNIG G, Durmus N
    Spotlight on Inflammation in Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2015;192:913-915.
    PubMed    


  197. TONELLI AR, Ahmed MK, Alkukhun L, Cikach F, et al
    Treprostinil Iontophoresis in Idiopathic Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2015;192:1014-6.
    PubMed    


  198. SINGER LG, Chowdhury NA, Faughnan ME, Granton J, et al
    Effects of Recipient Age and Diagnosis on Health-related Quality-of-Life Benefit of Lung Transplantation.
    Am J Respir Crit Care Med. 2015;192:965-73.
    PubMed     Abstract available


  199. PERROS F, Bonnet S
    Bone morphogenetic protein receptor type II and inflammation are bringing old concepts into the new pulmonary arterial hypertension world.
    Am J Respir Crit Care Med. 2015;192:777-9.
    PubMed    


    September 2015
  200. GONCHAROVA EA, Gladwin MT, Kawut SM
    Update in Pulmonary Vascular Diseases 2014.
    Am J Respir Crit Care Med. 2015;192:544-50.
    PubMed    


    August 2015
  201. DE JESUS PEREZ VA
    First among Equals: Nerve Growth Factor in the Pathogenesis of Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2015;192:274-5.
    PubMed    


  202. RHODES CJ, Im H, Cao A, Hennigs JK, et al
    RNA Sequencing Analysis Detection of a Novel Pathway of Endothelial Dysfunction in Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2015;192:356-66.
    PubMed     Abstract available


    July 2015
  203. SPIEKERKOETTER E, Sung YK, Sudheendra D, Bill M, et al
    Low-Dose FK506 (Tacrolimus) in End-Stage Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2015;192:254-7.
    PubMed    


  204. VAN HOUTEN B
    Pulmonary Arterial Hypertension Is Associated with Oxidative Stress-induced Genome Instability.
    Am J Respir Crit Care Med. 2015;192:129-30.
    PubMed    


  205. FEDERICI C, Drake KM, Rigelsky CM, McNelly LN, et al
    Increased Mutagen Sensitivity and DNA Damage in Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2015;192:219-28.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: